Cargando…

Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin

Around 70% of circulating alpha-2-antiplasmin (α2AP), the main natural plasmin inhibitor, is N-terminally cleaved between residues Pro12 and Asn13 by antiplasmin-cleaving enzyme. This converts native Met-α2AP into the more potent fibrinolysis inhibitor Asn-α2AP. The Arg6Trp (R6W) polymorphism affect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdul, Shiraazkhan, Peeters, Miet, Brouwers, Els, Malfliet, Joyce J. M. C., Leebeek, Frank W. G., Declerck, Paul J., Rijken, Dingeman C., Uitte de Willige, Shirley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933735/ https://www.ncbi.nlm.nih.gov/pubmed/29723259 http://dx.doi.org/10.1371/journal.pone.0196911

Ejemplares similares

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form
por: Abdul, Shiraazkhan, et al.
Publicado: (2020)

Inhibition of Fibrinolysis by Coagulation Factor XIII
por: Rijken, Dingeman C., et al.
Publicado: (2017)

Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease
por: Uitte de Willige, Shirley, et al.
Publicado: (2017)

Altered Behavior in Mice with Deletion of the Alpha2-Antiplasmin Gene
por: Kawashita, Eri, et al.
Publicado: (2014)

Alpha II Antiplasmin Deficiency Complicating Pregnancy: A Case Report
por: Dawley, Brenda
Publicado: (2011)

Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease
por: Singh, Satish, et al.
Publicado: (2020)

Alpha 2-antiplasmin deficiency in a Sudanese child: a case report
por: Mohammed, Bashir Abdrhman Bashir
Publicado: (2021)

Identification of Fibrin Clot-Bound Plasma Proteins
por: Talens, Simone, et al.
Publicado: (2012)

Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea
por: Zakrzewski, Maciej, et al.
Publicado: (2016)

Serum apolipoprotein A-II and alpha-2-antiplasmin levels in midtrimester can be used as predictors of preterm delivery
por: Huang, Jianxia, et al.
Publicado: (2020)

Development of a Universal Anti-Adalimumab Antibody Standard for Interlaboratory Harmonization
por: Gils, Ann, et al.
Publicado: (2014)

Generalizing Terwilliger's likelihood approach: a new score statistic to test for genetic association
por: el Galta, Rachid, et al.
Publicado: (2007)

α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis
por: Kanno, Yosuke, et al.
Publicado: (2022)

Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine
por: Liu, Jialu, et al.
Publicado: (2022)

Fibrin clot structure remains unaffected in young, healthy individuals after transient exposure to diesel exhaust
por: Metassan, Sofian, et al.
Publicado: (2010)

Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology
por: Kangro, Kadri, et al.
Publicado: (2023)

Increased urokinase and consumption of α(2)‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay
por: Longstaff, C., et al.
Publicado: (2018)

Plasma centrifugation does not influence thrombin-antithrombin and plasmin-antiplasmin levels but determines platelet microparticles count
por: Stępień, Ewa, et al.
Publicado: (2015)

α2-Antiplasmin as a potential regulator of the spatial memory process and age-related cognitive decline
por: Kawashita, Eri, et al.
Publicado: (2020)

Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson’s Disease
por: Sharma, Amit, et al.
Publicado: (2021)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin
Publicado: (1983)

Performance evaluation of thrombomodulin, thrombin‐antithrombin complex, plasmin‐α2‐antiplasmin complex, and t‐PA: PAI‐1 complex
por: Chen, Qian, et al.
Publicado: (2019)

Association of Genetic Polymorphisms of Fibrinogen, Factor XIII A-Subunit and α(2)-Antiplasmin with Fibrinogen Levels in Pregnant Women
por: Schwedler, Christian, et al.
Publicado: (2021)

Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
por: Bagoly, Zsuzsa, et al.
Publicado: (2017)

Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation
por: de Vries, Judith J., et al.
Publicado: (2020)

Plasma Clot Lysis Time and Its Association with Cardiovascular Risk Factors in Black Africans
por: de Lange, Zelda, et al.
Publicado: (2012)

A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
por: Vu, David M., et al.
Publicado: (2012)

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
por: Pretorius, Etheresia, et al.
Publicado: (2021)

Addition of a sequence from α(2)-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
por: Sheffield, William P, et al.
Publicado: (2009)

Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
por: Stephens, Amberley D., et al.
Publicado: (2020)

ERRATUM: A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
por: Vu, David M., et al.
Publicado: (2013)

Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review
por: de Vries, Judith J., et al.
Publicado: (2020)

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
por: Agadjanyan, Michael G., et al.
Publicado: (2017)

Bioinformatic Analysis of Na(+), K(+)-ATPase Regulation through Phosphorylation of the Alpha-Subunit N-Terminus
por: Blayney, Emma-Lucille, et al.
Publicado: (2022)

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2020)

In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time
por: de Lange, Zelda, et al.
Publicado: (2013)

The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
por: Bollen, Lize, et al.
Publicado: (2015)

Relation of α(2)-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis
por: Hoppe, Berthold, et al.
Publicado: (2020)

The N-terminus of the prion protein is a toxic effector regulated by the C-terminus
por: Wu, Bei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cm2v6es02i9gm1g8bcstdqqa0f